BackNeuberger Berman High Yield Strategies Fund Overview
Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Return on Equity

Latest ROE for Neuberger Berman High Yield Strategies Fund: 13.81% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

13.81%

Return on Equity

13.81%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Neuberger Berman High Yield Strategies Fund (NHS) FAQ

Neuberger Berman High Yield Strategies Fund posts a ROE of 13.81%. That is above the sector sector average of -5.87%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near -5.87% is typical. Neuberger Berman High Yield Strategies Fund's 13.81% is higher that level. That is roughly 335.3% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Neuberger Berman High Yield Strategies Fund's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 13.81%; use YoY and peer views to separate noise from signal.

Context for NHS's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -5.87%), and (3) consistency with growth and profitability. This page covers the first two; Neuberger Berman High Yield Strategies Fund's other metric pages and overview cover the third.